Unbiased AI-powered news
MDCalc is introducing ratings for its more than 800 clinical calculators used by doctors for decisions on disease risk and transplant eligibility. The system seeks to highlight validation limits in the tools. Health systems researcher Shazia Siddique joined the company last year and commented on the issue.
StatMDCalc is launching a quality-rating system for the more than 800 clinical calculators it hosts, @statnews reported July 17, 2026. The ratings will cover tools that doctors use daily to assess kidney performance, vaginal birth success after C-section, and other patient care factors.
Shazia Siddique, a health systems researcher and gastroenterologist who joined MDCalc last year, said the effort addresses a core problem.
“In clinical practice, a lot of the tools that we use, we genuinely have no idea how limited it is in its validation,” Siddique stated. The company plans to apply the ratings across its platform to increase transparency on how each calculator was developed and tested. MDCalc operates one of the largest collections of such decision-support tools in medicine.
Single source — no framing comparison available.
washingtonpost.comFlooding along the Guadalupe River has killed at least one person in central Texas. The same area recorded more than 130 deaths in flash floods last summer. Governor Greg Abbott confirmed the fatality in a Thursday update.
upi.comThe Food and Drug Administration approved enlicitide, sold as Lipfendra, on Thursday. Manufactured by Merck, the pill inhibits PCSK9 and cut LDL levels by up to 60 percent in a 24-week trial of 2,912 participants. It carries a list price of $315 for a 30-day supply and will reach…
flipboard.comEli Lilly will pay $2.8 billion in cash to acquire AtaiBeckley, a developer of psychedelic treatments for mental health conditions. The deal includes up to $1 billion in additional milestone payments. It adds the target’s compounds to Lilly’s neuroscience programs.